Epidemiology and Risk Factors for HCV Infection Among MSM With or at Risk of HIV in Madrid (2022–2024)
Year: 2025
Type: article
Study design: Observational Study
Abstract: Background: Ongoing high-risk behaviors continue to fuel HCV transmission among men who have sex with men (MSM), challenging elimination efforts. We studied HCV epidemiology in MSM with HIV (MSM-WH) and without HIV in the region of Madrid. Methods: This prospective study (2022-2024) enrolled MSM-WH from 10 centers and MSM on PrEP from an STI clinic. Visits were scheduled at baseline, 3, 6, 9, and 12 months (PrEP group), or baseline, 6, and 12 months (HIV group). Assessments included liver enzymes, HCV serology, HCV-RNA, and STI screening (syphilis, chlamydia, and gonorrhea by PCR). Results: A total of 1372 MSM (733 with HIV; 639 on PrEP) were enrolled. Baseline HCV prevalence was 1.68%, significantly higher in those with prior HCV exposure (5.60% vs 0.72%; prevalence ratio: 7.72, 95% CI: 3.31-18.03). Over 1240.4 person-years (PY) of follow-up, overall HCV incidence was 1.45/100 PY. Primary infection incidence was 0.79/100 PY: 0.94 in PrEP users versus 0.65 in MSM-WH (IRR: 1.44, 95% CI: .24-9.80). Reinfection incidence was 4.32/100 PY overall: 12.90 in PrEP users and 4.05 in MSM-WH (IRR: 3.21, 95% CI: .07-22.53). Two participants experienced within study reinfection (8.7/100 PY, 95% CI: 1.05-31.4). Slamsex and condomless receptive anal intercourse with ≥4 partners were independently associated with HCV infection and reinfection. Conclusions: MSM with prior HCV exposure had markedly higher HCV prevalence and incidence, regardless of HIV status. Risky sexual behaviors remain key drivers of HCV transmission. Behavior-informed prevention strategies are critical to sustain elimination efforts in MSM populations.
Source: Open Forum Infectious Diseases
DOI: 10.1093/ofid/ofaf678
Authors: Pablo Ryan, Juan Berenguer, Luis Ramos-Ruperto, Mar Vera, Luz Martín-Carbonero, Leire Pérez-Latorre, Ignacio De los Santos, Adriana Pinto, María J Vivancos, Eva Orviz, Beatriz Álvarez, José Sanz, Pilar Ruiz-Seco, Rafael Torres, Beatriz Brazal, Marta De Miguel, Beatriz López-Centeno, Inmaculada Jarrín, Salvador Resino, José M Bellón, Juan González-García
Institutions: Universidad Complutense de Madrid, Centro de Investigación Biomédica en Red, Hospital Universitario Infanta Leonor, Centro de Investigación Biomédica en Red Enfermedades Infecciosas, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Hospital Universitario La Paz, Hospital La Paz Institute for Health Research, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa, Research Institute Hospital 12 de Octubre, Hospital Universitario 12 De Octubre, Instituto Ramón y Cajal de Investigación Sanitaria, Hospital Universitario Ramón y Cajal, Hospital Universitario Fundación Jiménez Díaz, Hospital Universitario Príncipe de Asturias, Hospital Universitario Infanta Sofía, Universidad Europea de Madrid, Hospital Universitario Severo Ochoa, Fundación Seimc-Gesida, Madrid Health Service, Instituto de Salud Carlos III, Centro Nacional de Epidemiología, Centro Nacional de Microbiologia
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $4,053
Funder: Instituto de Salud Carlos III
Award: G1330327297
OpenAlex ID: W4416715590
